Haleon plc (HLN)

Haleon plc (HLN) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $45.6B; returns 1 day -1.0%, 1 week +1.4%, 1 year +9.6%.

Haleon plc is a global leader in consumer health, specializing in the development, manufacture, and marketing of a wide range of everyday health products. Spun off from GlaxoSmithKline (GSK) in July 2022, the company operates with a purpose to deliver better everyday health with humanity.

Groups HLN belongs to

• Dividend Payers
• Shrinking Share Count
• United Kingdom Companies
• Consumer HealthTech
• Healthcare
• Consumer Staples
• Consumer Products
• Consumer Goods
• Pain Management
• Digestive Health
• Health and Wellness Products
• Dietary Supplements
• Over-the-Counter Drugs
• Personal Care

HLN financial model: income statement, cash flow and balance sheet